{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:15:24Z","timestamp":1760426124782,"version":"build-2065373602"},"reference-count":40,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Clonidine, an alpha-2 adrenergic agonist, has been proposed as an antimanic agent that acts by reducing noradrenergic transmission. We conducted a systematic review to examine the efficacy and safety of clonidine for acute mania\/hypomania. A comprehensive literature search was performed to identify randomized controlled trials (RCT) and non-randomized studies investigating the efficacy and safety of monotherapy\/adjuvant treatment with clonidine for acute mania\/hypomania in patients with bipolar disorder (BD). Nine studies (n = 222) met our inclusion criteria, including five RCTs (n = 159) and four non-randomized studies (n = 63). Non-randomized studies showed clonidine to help reduce symptoms of mania. However, data from placebo controlled RCTs were inconsistent. One RCT showed adjuvant clonidine as superior to placebo, whereas another RCT reported that clonidine was not better than placebo. In individual RCTs, lithium and valproate offered better antimanic effects compared to clonidine. Studies reported hypotension, depression, and somnolence as common adverse effects. Significant differences in study design and sample size contributed to high heterogeneity. This systematic review suggests low-grade evidence for clonidine as an adjuvant treatment for acute mania with mood stabilizers and inconclusive efficacy as monotherapy, warranting further well-designed RCTs.<\/jats:p>","DOI":"10.3390\/brainsci13040547","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T03:31:48Z","timestamp":1679887908000},"page":"547","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and Safety of Clonidine in the Treatment of Acute Mania in Bipolar Disorder: A Systematic Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6524-5453","authenticated-orcid":false,"given":"Prakamya","family":"Singal","sequence":"first","affiliation":[{"name":"Department of Psychiatry, All India Institute of Medical Sciences, New Delhi 110029, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas A.","family":"Nu\u00f1ez","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1576-9344","authenticated-orcid":false,"given":"Boney","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN 55905, USA"},{"name":"Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1889-8387","authenticated-orcid":false,"given":"Leslie C.","family":"Hassett","sequence":"additional","affiliation":[{"name":"Mayo Clinic Libraries, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Seshadri","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7062-8192","authenticated-orcid":false,"given":"Balwinder","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1590\/1516-4446-2012-1693","article-title":"Bipolar disorder prevalence: A systematic review and meta-analysis of the literature","volume":"37","author":"Clemente","year":"2015","journal-title":"Braz. J. Psychiatry"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_3","unstructured":"Goodwin, F.K., and Jamison, K.R. (2007). Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, Oxford University Press."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2147\/NDT.S273503","article-title":"Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions","volume":"18","author":"Elsayed","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/bdi.13208","article-title":"Predictors of functional impairment in bipolar disorder: Results from 13 cohorts from seven countries by the global bipolar cohort collaborative","volume":"24","author":"Burdick","year":"2022","journal-title":"Bipolar Disord."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2045125320905752","DOI":"10.1177\/2045125320905752","article-title":"Cariprazine as a treatment across the bipolar I spectrum from depression to mania: Mechanism of action and review of clinical data","volume":"10","author":"Stahl","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00213-018-5102-6","article-title":"Second-generation antipsychotics and metabolism alterations: A systematic review of the role of the gut microbiome","volume":"236","author":"Misera","year":"2019","journal-title":"Psychopharmacology"},{"key":"ref_11","first-page":"599","article-title":"Jr The current status of research in the catecholamine theories of affective disorders","volume":"1","author":"Bunney","year":"1975","journal-title":"Psychopharmacol. Commun."},{"key":"ref_12","first-page":"136","article-title":"The underlying neurobiology of bipolar disorder","volume":"2","author":"Manji","year":"2003","journal-title":"World Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2174\/1570159X14666160902145635","article-title":"Is mania the hypertension of the mood? Discussion of a hypothesis","volume":"15","author":"Rihmer","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1176\/ajp.143.11.1450","article-title":"Efficacy of clonidine in 24 patients with acute mania","volume":"143","author":"Hardy","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"ref_15","first-page":"209","article-title":"The effect of clonidine in the treatment of acute mania","volume":"29","author":"Tudorache","year":"1991","journal-title":"Rev. Roum. Neurol. Et Psychiatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1176\/ajp.141.12.1617","article-title":"Clonidine in the treatment of mania and mixed bipolar disorder","volume":"141","author":"Zubenko","year":"1984","journal-title":"Am. J. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000446441","article-title":"Clonidine use in psychiatry: Panacea or panache?","volume":"98","author":"Naguy","year":"2016","journal-title":"Pharmacology"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Stahl, S.M. (2021). Stahl\u2019s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, Cambridge University Press.","DOI":"10.1017\/9781108975292"},{"key":"ref_19","unstructured":"Yasaei, R., and Saadabadi, A. (2022). StatPearls [Internet], StatPearls Publishing."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/00005344-198000021-00002","article-title":"Clonidine in the central nervous system: Site and mechanism of hypotensive action","volume":"2","author":"Isaac","year":"1980","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/wps.20481","article-title":"The promise and challenges of drug repurposing in psychiatry","volume":"17","author":"Fava","year":"2018","journal-title":"World Psychiatry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpsychires.2021.12.035","article-title":"Influence of adjuvant clonidine on mania, sleep disturbances and cognitive performance\u2014Results from a double-blind and placebo-controlled randomized study in individuals with bipolar I disorder during their manic phase","volume":"146","author":"Ahmadpanah","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"W-65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (MINORS): Development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/JCP.0000000000001317","article-title":"A systematic review on the efficacy of intravenous racemic ketamine for bipolar depression","volume":"41","author":"Joseph","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/JCP.0000000000001475","article-title":"Association of optimal lamotrigine serum levels and therapeutic efficacy in mood disorders: A systematic review","volume":"41","author":"Kumar","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_28","first-page":"243","article-title":"A double-blind, placebo-controlled trial of clonidine in the treatment of acute mania","volume":"25","author":"Janicak","year":"1989","journal-title":"Psychopharmacol. Bull."},{"key":"ref_29","first-page":"523","article-title":"Clonidine versus a placebo trial in manic disorder","volume":"15","author":"Lecrubier","year":"1989","journal-title":"L\u2019encephale"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/j.1552-4604.1985.tb02845.x","article-title":"Comparison of antimanic efficacy of clonidine and verapamil","volume":"25","author":"Giannini","year":"1985","journal-title":"J. Clin. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1176\/ajp.143.12.1608","article-title":"Comparison of clonidine and lithium in the treatment of mania","volume":"143","author":"Giannini","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1176\/ajp.137.10.1275","article-title":"Antimanic effect of clonidine","volume":"137","author":"Jouvent","year":"1980","journal-title":"Am. J. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ddr.430030112","article-title":"Clonidine in mania","volume":"3","author":"Giannini","year":"1983","journal-title":"Drug Dev. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0028-3908(78)90022-9","article-title":"The mania rating scale: Scale construction and inter-observer agreement","volume":"17","author":"Bech","year":"1978","journal-title":"Neuropharmacology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.31887\/DCNS.2011.13.1\/ccelano","article-title":"Depressogenic effects of medications: A review","volume":"13","author":"Celano","year":"2022","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/idoj.IDOJ_475_18","article-title":"Clinical Trial Designs","volume":"10","author":"Nair","year":"2019","journal-title":"Indian Dermatol. Online J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","article-title":"The catecholamine hypothesis of affective disorders: A review of supporting evidence","volume":"122","author":"Schildkraut","year":"1965","journal-title":"Am. J. Psychiatry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jpsychires.2021.09.018","article-title":"Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials","volume":"143","author":"Bartoli","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/0006-2952(74)90187-7","article-title":"Presynaptic regulation of catecholamine release","volume":"23","author":"Langer","year":"1974","journal-title":"Biochem. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1176\/ajp.144.8.1099b","article-title":"Propranolol as adjunct to clonidine in opiate detoxification","volume":"144","author":"Roehrich","year":"1987","journal-title":"Am. J. Psychiatry"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/13\/4\/547\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:02:59Z","timestamp":1760122979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/13\/4\/547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,25]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["brainsci13040547"],"URL":"https:\/\/doi.org\/10.3390\/brainsci13040547","relation":{},"ISSN":["2076-3425"],"issn-type":[{"type":"electronic","value":"2076-3425"}],"subject":[],"published":{"date-parts":[[2023,3,25]]}}}